India, July 31 -- Gurugram-based Iberia Pharmaceuticals has announced its new hi-tech manufacturing and research facility spread across 60000 sq. ft. in Jhajjar, Haryana. The next-generation unit is expected to be operational by mid of 2026.

The facility is designed to serve customers with science-baked, derma-driven, wellness products. The company has made a massive investment of Rs 70 crore and is proud to be a part of the government backed 'Make-in-India' movement.

This unit is equipped with best-in-class control systems and equipment. The facility will be supported by an experienced team that will be committed to ensuring large-scale commercial manufacturing is carried on smoothly. The scale of manufacturing will not compromise on i...